Survodutide — Dosage Calculator & Complete GuideCategory: GLP-1 Agonist | Half-Life: ~6 days | Route: SubQDual GLP-1/glucagon receptor agonist showing up to 19% weight loss in Phase 2 trials. Also shows promise for fatty liver disease (MASH).Dosing Information

Starting Dose: 0.3mg weekly

Target Dose: 2.4-4.8mg weekly

Research Status: Phase 3 clinical trials

Primary Uses

Obesity

Type 2 diabetes

MASH/NAFLD

Benefits

Strong weight loss (up to 19%)

Liver fat reduction

Dual receptor mechanism

Metabolic improvements

Calculate Survodutide DoseUse VialDex to calculate the exact reconstitution volume and syringe dose for Survodutide. Enter your vial size and BAC water volume for instant results.Open VialDex Calculator | Browse All Peptides | Check Compatibility

VIALDEX